We market well.

Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.

Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.

Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.

A CASE STUDY CLICK HERE
to review a copy of the book
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.

People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
SEE MORE
recent work right here
The Medical News
WASHINGTON (Reuters) - President Donald Trump made calls to fellow Republicans in the U.S. Senate on Friday to mobilize support for their party's healthcare overhaul while acknowledging the legislation is on a "very, very narrow path" to passage.... CHICAGO (Reuters) - The U.S. Department of Agriculture has found repeated import violations in raw Brazilian beef, including abscesses and unidentified foreign material, a top agency official said, explaining reasons for a U.S. ban on imports of fresh Brazilian beef.... NEW YORK (Reuters) - Health insurers are concerned about the U.S. Senate's plans to cut the Medicaid program for the poor and the impact such a move would have on state governments, the industry's largest lobbyist said on Friday.... ZURICH (Reuters) - A European Medicines Agency (EMA) panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer.... (Reuters) - A handful of drugmakers are taking their first steps toward developing marijuana-based painkillers, alternatives to opioids that have led to widespread abuse and caused the U.S. health regulator to ask for a withdrawal of a popular drug this month.... DUBAI (Reuters) - Saudi Arabia's crown prince has donated $66.7 million to combat a cholera epidemic in Yemen, where a Saudi-led coalition is fighting in a war blamed for causing a humanitarian disaster.... PORT-AU-PRINCE, Haiti (Reuters) - The United Nations stressed on Thursday its support for eradicating cholera in Haiti, an epidemic it accidentally started, although the government said residents would be better served if aid funding was channeled through it.... WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved a new oral blood-thinner made by Portola Pharmaceuticals Inc to prevent deep vein thrombosis and pulmonary embolisms in acutely ill patients who are not undergoing surgery.... COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved GLP-1 drug called semaglutide, showed a weight loss of up to 13.8 percent in people with severe conditions.... (This June 23 story corrects second paragraph to show that the recommendation is to approve the relapsing forms, not the relapsing-remitting form of MS.)...